X
X

Dr. Akshay Bedmutha

   MBBS, DNB (Nuclear Medicine and Molecular Imaging)

Book An Appointment

Home / Doctors / Dr. Akshay Bedmutha

Dr. Akshay Bedmutha

  Qualification

MBBS, DNB (Nuclear Medicine and Molecular Imaging)

  Specialities

Nuclear Medicine

  Locations

HCG Cancer Centre - Ahmedabad

  Experience

5 Years

Introduction
Expertise
  • Dr. Akshay has vast experience in PET-CT with various tracers (FDG, PSMA, DOTANOC, FET etc.) for different tumour types. 
  • He is also experienced in handling therapeutic nuclear medicine procedures, like I-131 therapy for thyroid cancer, Lu-177 PRRT for neuroendocrine tumours and Lu-177 PSMA therapy for prostate cancers.
Training and Certifications
  • Dr. Akshay is a certified Radiological Safety Officer by Atomic Energy Regulatory Board, India.
Recognition
  • He serves as an EC member of the western chapter of the Society of Nuclear Medicine India.
Publications
  • Gallbladder malakoplakia masquerading as malignant primary on 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):323-324.
  • Epithelioid angiosarcoma: 10 years postrenal transplant. (2017) South Asian Journal of cancer, 6(02), 058-063.
  • FDG PET/CT of Primary Ewing Sarcoma of IVC. Clin Nucl Med. 2020 Feb;45(2):e112-e114.
  • Metabolic Imaging as a Novel Strategy in Evaluation of Mycotic Abdominal Aortic Aneurysm: A Case Report and Brief Clinical Review. Indian J Nucl Med. 2017 Oct-Dec;32(4):336-339.
  • FDG PET/CT of Primary Ewing Sarcoma of IVC, Clinical Nuclear Medicine: February 2020 - Volume 45 - Issue 2 - p e112-e114
  • 18F-fludeoxyglucose positron emission tomography computed tomography-guided diagnosis of prostatic and leptomeningeal tuberculosis, Indian J Urol. 2017 Oct-Dec; 33(4): 325–327.
  • Gallbladder malakoplakia masquerading as malignant primary on 18F-FDG PET/CT, European Journal of Nuclear Medicine and Molecular Imaging volume 48, pages323–324 (2021)
  • Metabolic Imaging as a Novel Strategy in Evaluation of Mycotic Abdominal Aortic Aneurysm: A Case Report and Brief Clinical Review, Indian J Nucl Med. 2017 Oct-Dec; 32(4): 336–339
  • Unusual case of infantile fibrosarcoma evaluated on F-18 fluorodeoxyglucose positron emission tomography-computed tomography, Indian J Nucl Med. 2016 Jul-Sep; 31(3): 201–203
  • Epithelioid angiosarcoma: 10 years postrenal transplant, South Asian J Cancer 2017;6:58-63.
  • FDG PET/CT for assessing marrow involvement at staging pediatric nonhematological round cell malignancies, Nuclear Medicine Communications, 07 Oct 2021.
  • Widely disseminated metastatic Ewing sarcoma: Sustained, complete metabolic response to first-line oral metronomic chemotherapy, 17 June 2020.
  • Utility of 18F-FDG PET/CT based Metabolic Parameters in Differentiating Malignant Brain SOLs, 2020
  • Assessment of prognostic value of baseline (18) FDG PET/CT metabolic parameters (SUV max, MTV and TLG) and treatment response on (18) FDG PET/CT scan in patients of Langerhan, 2020/9/1, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Predictive Value of Intratumoral Metabolic Heterogeneity in terms of Disease Free Survival in Hormone Receptor Positive Invasive Ductal Carcinoma Breast, 2016/10/1, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

   Practices at

Other Doctors

HCG Call Icon